Cart
sales@molnova.com
DMAB-anabaseine dihydrochloride
CAS No. 154149-38-9
DMAB-anabaseine dihydrochloride( N,N-dimethyl-4-[(E)-(6-pyridin-3-yl-3,4-dihydro-2H-pyridin-5-ylidene)methyl]aniline | dihydrochloride )
Catalog No. M27623 CAS No. 154149-38-9
DMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 170 | Get Quote |
|
| 10MG | 245 | Get Quote |
|
| 25MG | 412 | Get Quote |
|
| 50MG | 606 | Get Quote |
|
| 100MG | 862 | Get Quote |
|
| 500MG | 1728 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDMAB-anabaseine dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionDMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.
-
DescriptionDMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.
-
In Vitro——
-
In Vivo——
-
SynonymsN,N-dimethyl-4-[(E)-(6-pyridin-3-yl-3,4-dihydro-2H-pyridin-5-ylidene)methyl]aniline | dihydrochloride
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number154149-38-9
-
Formula Weight364.31
-
Molecular FormulaC19H23Cl2N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.CN(C)c1ccc(\C=C2/CCCN=C2c2cccnc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.1. Nouioua S, et al. Creatine deficiency syndrome. A treatable myopathy due to arginine-glycine amidinotransferase (AGAT) deficiency. Neuromuscul Disord. 2013 Aug;23(8):670-4.
molnova catalog
related products
-
Tiotropium Bromide h...
Tiotropium Bromide hydrate (BA-679 BR hydrate) is a potent anticholinergic and bronchodilator, serving as a muscarinic receptor antagonist, specifically targeting mAChR.
-
LY2033298
LY2033298, a positive allosteric modulator of muscarine M4 receptor, enhances the inhibitory effect of oximoline on light-induced phase shift in circadian activity in hamsters and can be used in neurosystem-related diseases.
-
SIB 1553A
SIB 1553A is an orally available and selective agonist of nicotinic acetylcholine receptors (nAChRs), which are subtype-selective ligands for nicotinic acetylcholine receptors.
